(A) The Hepatic Insulin Sensitivity Index was reduced in subjects with hepatic steatosis, but did not differ between subjects with mild or severe steatosis. The index was calculated as 100 / (fasting plasma insulin x basal endogenous glucose production).
(B) Expressing peripheral insulin sensitivity as percentage increase relative to basal glucose uptake yielded similar results.
(C) Expressing peripheral insulin sensitivity relative to lean body mass yielded similar results.
(D) Insulin clearance during low-dose insulin infusion (step 1 of the clamp) did not differ between subjects with varying extent of steatosis. Insulin clearance was calculated as insulin infusion rate / plasma insulin concentration during the clamp.
(E) Insulin clearance during high-dose insulin infusion (step 2) did not differ between subjects with varying extent of steatosis.
Data are mean ± SEM (n = 133). Rate of disappearance (Rd), fat-free mass (FFM). ** p < 0.01 vs no steatosis. *** p < 0.001 vs no steatosis. Lines were fitted by least squares method (n = 25-29). Diacylglycerol (DAG), endogenous glucose production (EGP). 130 100.9 ± 5.9 Highly abundant species that were also related to hepatic insulin sensitivity are highlighted. Diacylglycerol (DAG), endogenous glucose production (EGP). 9.2 ± 3.0 14.2 ± 2.6 0.209 Data are count (%) or mean ± SEM. Hepatic insulin sensitivity and resistance were defined as insulin suppression of EGP > 80% and < 65%, respectively. Endogenous glucose production (EGP), intrahepatic triglyceride (IHTG). a Groups were compared by 2-tailed independent samples t test. Data were fitted by least squares method (n = 28). Diacylglycerol (DAG), fatty acids (FA).
